Pharmacological and clinical evaluation of afatinib for the treatment of NSCLCHUO Xiu-ying, FENG Yu-fei1473-1476
Quality system for security of drug quality control data in laboratory computersLI Jian, XIANG Xin-hua, CHEN Wei1477-1483
Discussion on the countermeasure to the drug emergency inspection managementLIN Lan, GAO Zhi-feng1484-1486
Analysis of main problems for CMC changes of the post-approval chemical drugsYANG Jian-hong1487-1492,1524
Determination of lysolipid in vinorelbine liposome for injection by HPLC-charged aerosol detectorLI Han, GONG Wei, ZHANG Hui, MEI Xing-guo1493-1496
UPLC determination of ginsenoside Rh1 and Rh2 in secondary ginsenoside H dripping pillZHOU Hong-yu, WANG Yu, SONG Zhao-hui, ZHANG Lan-lan, ZHOU Shui-ping, FENG Feng1497-1500
Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countriesZHANG Yi-fan, ZHONG Da-fang1501-1505
GastroPlus simulation technology for evaluating the bioequivalence of cefdinir capsulesPAN Rui-xue, YU Fang-jian, ZOU Wen-bo, HU Chang-qin1506-1513
U.S.FDA drug safety information communication platform and drug quality reporting systemGeorge R.Bolger, TU Yong-rui, SUN Pei-hua, XIE Guo-wei, QIAO Wei-dong, ZHANG Hong1514-1520
Preparation and comparison of concealment allocation methods of alternative vaccine in double-blinded clinical vaccine trialsKONG Yu-jia, WANG Ling, JIANG Zhi-wei, LI Chan-juan, XIA Jie-lai1521-1524